Resources from the same session
Welcome and Introductions
Presenter: Martin Reck
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
Development of an MDM2-p53 Antagonist for STS and Other Indications
Presenter: Patrick Schoeffski
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
Targeting HER2 and KRAS to Deliver Breakthrough Therapies
Presenter: Egbert Smit
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
T-cell Engagers: Change of the Treatment Paradigm in Solid Tumors
Presenter: Martin Reck
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
Closing Remarks
Presenter: Martin Reck
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast